At a glance
ClinicalIndex Comparison RecordN/ACompleted· 411 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prostate Cancer Screening Trial Using A Group of Radiological Approaches Including MRI and Ultrasound
In Brief
An observational study for Prostate Neoplasm. Completed, enrolled 411 participants across 1 site.
Detailed Summary
Participants will be recruited from the community and attend a screening clinic and undergo the following screening tests: 1. Bi-parametric MRI - reported by a radiologist and CAD-AI system 2. Multiparametric ultrasound - including shearwave elastography 3. A standard-of-care PSA test A systematic +/- targeted biopsy will be performed if any tests are positive, independent of the other tests.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsProstate Neoplasm
CountriesUnited Kingdom
CollaboratorsImperial College Healthcare NHS Trust
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartOct 2018
First PostedOct 2018
Primary CompletionMay 2019
Study CompletionAug 2019
TodayJul 2026
First PostedOct 11, 2018
Enrollment StartOct 10, 2018
Primary CompletionMay 15, 2019
Study CompletionAug 22, 2019
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 7.7 years ago